Literature DB >> 7528724

Primate terminal complement inhibitor homologues of human CD59.

W L Fodor1, S A Rollins, S Bianco-Caron, W V Burton, E R Guilmette, R P Rother, G B Zavoico, S P Squinto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7528724     DOI： 10.1007/BF00188435

Source DB:  PubMed          Journal:  Immunogenetics        ISSN： 0093-7711            Impact factor:   2.846


× No keyword cloud information.
  2 in total

1.  Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9.

Authors:  S A Rollins; J Zhao; H Ninomiya; P J Sims
Journal:  J Immunol       Date:  1991-04-01       Impact factor: 5.422

2.  Inhibition of complement-mediated cytolysis by the terminal complement inhibitor of herpesvirus saimiri.

Authors:  R P Rother; S A Rollins; W L Fodor; J C Albrecht; E Setter; B Fleckenstein; S P Squinto
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103
  2 in total
  6 in total

1.  Binding of human and rat CD59 to the terminal complement complexes.

Authors:  T Lehto; B P Morgan; S Meri
Journal:  Immunology       Date:  1997-01       Impact factor: 7.397

2.  Mutational analysis of the active site and antibody epitopes of the complement-inhibitory glycoprotein, CD59.

Authors:  D L Bodian; S J Davis; B P Morgan; N K Rushmere
Journal:  J Exp Med       Date:  1997-02-03       Impact factor: 14.307

3.  Characterization of the mouse analogues of CD59 using novel monoclonal antibodies: tissue distribution and functional comparison.

Authors:  Claire L Harris; S Melanie Hanna; Masashi Mizuno; Dewi S Holt; Kevin J Marchbank; B Paul Morgan
Journal:  Immunology       Date:  2003-05       Impact factor: 7.397

4.  Structural composition and functional characterization of soluble CD59: heterogeneity of the oligosaccharide and glycophosphoinositol (GPI) anchor revealed by laser-desorption mass spectrometric analysis.

Authors:  S Meri; T Lehto; C W Sutton; J Tyynelä; M Baumann
Journal:  Biochem J       Date:  1996-06-15       Impact factor: 3.857

5.  Mapping the active site of CD59.

Authors:  J Yu; R Abagyan; S Dong; A Gilbert; V Nussenzweig; S Tomlinson
Journal:  J Exp Med       Date:  1997-02-17       Impact factor: 14.307

6.  Characterization in vitro and in vivo of the pig analogue of human CD59 using new monoclonal antibodies.

Authors:  S M Hanna; G T Williams; C W Van Den Berg; B P Morgan
Journal:  Immunology       Date:  1998-11       Impact factor: 7.397
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.